Grossman Jerrold B
SEC Form 4 insider trading activity
Grossman Jerrold B has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: May 28, 2026.
On the most recent filing, Grossman Jerrold B is listed as Director at ADMA BIOLOGICS, INC. Inside the rolling window, Grossman Jerrold B reported 3 open-market purchases totaling $251K in ADMA and no open-market sales. The largest disclosed transaction in the window is a purchase of 12,500 ADMA shares on May 12, 2026, worth $100K.
Companies traded
Other insiders at ADMA
Insider Buying
$251K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Grossman Jerrold B made?
Grossman Jerrold B has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Grossman Jerrold B trade?
Grossman Jerrold B has filed SEC Form 4 disclosures for 1 company, including ADMA.
When was Grossman Jerrold B's most recent SEC Form 4 filing?
Grossman Jerrold B's most recent SEC Form 4 filing on Tracefour is dated May 28, 2026.
What is Grossman Jerrold B's total buy and sell value in the current window?
Inside the rolling retention window, Grossman Jerrold B bought $251K and sold $0 based on SEC Form 4 filings.
What was Grossman Jerrold B's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,500 ADMA shares on 2026-05-12, worth $100K, per SEC Form 4 filings.